Pharmaceutical salts: A summary on doses of salt formers from the Orange Book

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 4, 2013, Pages 614-623

  Saal, C ^a   Becker, A ^a  

^a MERCK KGAA   (Germany)

Author keywords

Counter ions; Drug development; Pharmaceutical salts; Salt screening; Salt selection; Toxicology

Indexed keywords

ACETIC ACID; AMLODIPINE BESYLATE; ATRACURIUM BESILATE; BENZOIC ACID; BROMIDE; CARBONIC ACID; CASPOFUNGIN; CITRIC ACID; DESMOPRESSIN ACETATE; DEXTROPROPOXYPHENE NAPSILATE; EMBONIC ACID; FUMARIC ACID; GLUCOHEPTONIC ACID; GLUCONIC ACID; GLUCURONIC ACID; HIPPURIC ACID; INORGANIC SALT; IODIDE; ISETHIONIC ACID; LACTIC ACID; LACTOBIONIC ACID; LITHIUM CARBONATE; MALEIC ACID; MALIC ACID; MESORIDAZINE BESYLATE; MESYLIC ACID; NITRATE; OXALIC ACID; PYRIDOSTIGMINE; SULFATE;

ARTICLE; CHEMICAL STRUCTURE; DIETARY REFERENCE INTAKE; DISSOLUTION; DRUG ADMINISTRATION ROUTE; DRUG DOSE; DRUG SCREENING; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STOICHIOMETRY; TOXICITY;

EID: 84879478391     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.05.026     Document Type: Review

References (21)

1. Drug Information Online Database, (assessed 28.12.12). European Comission, SCCNFP, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers, June 2002.
2. European Comission. Recommendation from the Scientific Committee on Occupational Exposure Limits for Acetic Acid, June 2012.
3. Elder, D.P., Delaney, E., Teasdale, A., Eyley, S., Reif, V.D., Jacq, K., Facchine, K.L., Oestrich, R.S., Sandra, P., David, F., 2010. The utility of sulfonate salts in drug development. J. Pharm. Sci. 99, 2948-2961.
4. European Medicines Agency, Press Release 20th September 2007, CHMP Assessment Report for Viracept, London. EMEA/H/C/164/Z/109.
5. European Medicines Agency agrees on action plan following the recall of Viracept and recommends suspension of the marketing authorization, London. EMEA/275367/2007.
6. FDA Orange Book. (assessed 28.12.12).
7. FDAa, 2012. US Food and Drug Administration, Maximum Recommended Therapeutic Dose (MRTD) Database, (assessed 28.12.12).
8. FDA, 2013. , 05/04/2011-FDA-FAQs on KI (assessed 5.05.13).
9. Gould, P.L., 1986. Salt selection for basic drugs. Int. J. Pharm. 33, 201-217. (Pubitemid 17197805)
10. Institute of Medicine, 2013. Dietary reference intakes: water, potassium, sodium, chloride, and sulfate, from the Institute of Medicine of the National Academies: , (assessed 5.05.13).
11. Liu, R., 2008. Water-Insoluble Drug Formulation. CRC Press.
12. NIH Medline Plus, New Recommended Daily Amounts of Calcium and Vitamin D3, 2001. (assessed 5.05.13).
13. Paulekuhn, S., Dressman, J.B., Saal, C., 2007. Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database. J. Med. Chem. 50, 6665-6672. (Pubitemid 350309103)
14. Pfannkuch, F., Rettig, H., Stahl, P.H., 2011. Biological effects of the API salt form. In: Stahl, P.H., Wermuth, C.G. (Eds.), Handbook of Pharmaceutical Salts. VHCA, Verlag Helvetica Chimica Acta, Zürich and Wiley-VCH, Weinheim, pp. 125-146.
15. Prohotsky, D.L., Zhao, F., 2012. A survey of top 200 drugs-inconsistent practice of drug strength expression for drugs containing salt forms. J. Pharm. Sci. 10, 1-6.
16. Swissmedic Department of Control of the Medicinal Products Market, 23rd October 2007. Mesylate ester type impurity contained in medicinal products.
17. Steinhilber, D., Schubert-Zsilavecz, M., Roth, H.J., 2005. Medizinsche Chemie. Deutscher Apotheker Verlag.
18. Thackaberry, E.A., 2012. Non-clinical toxicological considerations of pharmaceutical salt selection. Exp. Opin. Drug Metab. Toxicol. 8, 1419-1433.
19. Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., Savolainen, J., 2008. Prodrugs: design and clinical applications. Nat. Rev. Drug Disc. 7, 255-270. (Pubitemid 351324639)
20. Stahl, P.H., Wermuth, C.G. (Eds.), 2011. Handbook of Pharmaceutical Salts. VHCA, Verlag Helvetica Chimica Acta, Zürich and Wiley-VCH, Weinheim.
21. US Pharmacopeia 35, 2012. Amikacin Sulfate. (assessed 14.01.12).